Background Inflammatory bowel disease (IBD) follows a heterogenous disease course and
predicting a patient's prognosis is challenging. There is a wide burden of illness in IBD and …

Inflammatory bowel disease is characterized by significant interindividual heterogeneity.
With a wider selection of pharmacologic and nonpharmacologic interventions available and …

Background Ferroptosis, a unique form of non-apoptotic cell death, is dependent on iron and
lipoperoxidation, and has been shown to be associated with the pathogenesis of …

METHODS: Through a systematic review of multiple databases through August 31, 2020, we
identified randomized controlled trials in patients with IBD comparing digital health …

Artificial intelligence shows promise for clinical research in inflammatory bowel disease
endoscopy. Accurate assessment of endoscopic activity is important in clinical practice and …

Advances in science have led to the development of multiple biologics and small molecules
for the treatment of inflammatory bowel diseases (IBDs). This growth in advanced medical …

Abstract Treatment options for the medical management of inflammatory bowel disease
(IBD) have expanded substantially over the past decade. Multiple classes of advanced …

Abstract Background and Aims Heterogeneity of treatment effects in inflammatory bowel
disease means that many individuals or patient subgroups depart from the average for …

Integrating artificial intelligence into inflammatory bowel disease (IBD) has the potential to
revolutionise clinical practice and research. Artificial intelligence harnesses advanced …

Background Patients with inflammatory bowel diseases (IBD) sometimes require
investigational medicinal therapy in a clinical trial. Before enrollment, patients must meet …